BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11102463)

  • 1. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo.
    Strelau J; Sullivan A; Böttner M; Lingor P; Falkenstein E; Suter-Crazzolara C; Galter D; Jaszai J; Krieglstein K; Unsicker K
    J Neurosci; 2000 Dec; 20(23):8597-603. PubMed ID: 11102463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning.
    Strelau J; Schober A; Sullivan A; Schilling L; Unsicker K
    J Neural Transm Suppl; 2003; (65):197-203. PubMed ID: 12946057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Machado V; Haas SJ; von Bohlen Und Halbach O; Wree A; Krieglstein K; Unsicker K; Spittau B
    Neurobiol Dis; 2016 Apr; 88():1-15. PubMed ID: 26733415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short communication: transforming growth factor-beta mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons.
    Krieglstein K; Reuss B; Maysinger D; Unsicker K
    Eur J Neurosci; 1998 Aug; 10(8):2746-50. PubMed ID: 9767406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF-15/MIC-1 a novel member of the TGF-beta superfamily.
    Strelau J; Böttner M; Lingor P; Suter-Crazzolara C; Galter D; Jaszai J; Sullivan A; Schober A; Krieglstein K; Unsicker K
    J Neural Transm Suppl; 2000; (60):273-6. PubMed ID: 11205146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons.
    Krieglstein K; Suter-Crazzolara C; Hötten G; Pohl J; Unsicker K
    J Neurosci Res; 1995 Dec; 42(5):724-32. PubMed ID: 8600306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain.
    Schober A; Böttner M; Strelau J; Kinscherf R; Bonaterra GA; Barth M; Schilling L; Fairlie WD; Breit SN; Unsicker K
    J Comp Neurol; 2001 Oct; 439(1):32-45. PubMed ID: 11579380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice.
    Machado V; Gilsbach R; Das R; Schober A; Bogatyreva L; Hauschke D; Krieglstein K; Unsicker K; Spittau B
    Cell Tissue Res; 2016 Aug; 365(2):209-23. PubMed ID: 27115420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity.
    Krieglstein K; Unsicker K
    Neuroscience; 1994 Dec; 63(4):1189-96. PubMed ID: 7700516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues.
    Böttner M; Suter-Crazzolara C; Schober A; Unsicker K
    Cell Tissue Res; 1999 Jul; 297(1):103-10. PubMed ID: 10398887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta and the regulation of neuron survival and death.
    Krieglstein K; Strelau J; Schober A; Sullivan A; Unsicker K
    J Physiol Paris; 2002; 96(1-2):25-30. PubMed ID: 11755780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease.
    Hurley FM; Costello DJ; Sullivan AM
    Exp Neurol; 2004 Feb; 185(2):281-9. PubMed ID: 14736509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo.
    Farkas LM; Dünker N; Roussa E; Unsicker K; Krieglstein K
    J Neurosci; 2003 Jun; 23(12):5178-86. PubMed ID: 12832542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
    Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
    Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures.
    Zhang L; Fletcher-Turner A; Marchionni MA; Apparsundaram S; Lundgren KH; Yurek DM; Seroogy KB
    J Neurochem; 2004 Dec; 91(6):1358-68. PubMed ID: 15584912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
    Opacka-Juffry J; Ashworth S; Hume SP; Martin D; Brooks DJ; Blunt SB
    Neuroreport; 1995 Dec; 7(1):348-52. PubMed ID: 8742486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta in dopamine neuron development, maintenance and neuroprotection.
    Roussa E; von Bohlen und Halbach O; Krieglstein K
    Adv Exp Med Biol; 2009; 651():81-90. PubMed ID: 19731553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.